Phenprobamate

• CAT Number: I034632
• CAS Number: 673-31-4
• Molecular Formula: C10H13NO2
• Molecular Weight: 179.22
• Purity: 98%
• Synonyms: Phenprobamate; MH532; MH 532; MH-532
• Solubility: To be determined
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 1-Propanol, 3-phenyl-, carbamate
• InChI: InChI=1S/C10H13NO2/c11-10(12)13-8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H2,11,12)
• InChIKey: CAMYKONBWHRPDD-UHFFFAOYSA-N
• SMILES: NC(OCCCC1=CC=CC=C1)=O

Phenprobamate (Cat No.: I034632) is a centrally acting muscle relaxant with sedative and anxiolytic properties. It functions by modulating GABAergic activity in the central nervous system, leading to muscle relaxation and mild anticonvulsant effects. Previously used for conditions like muscle spasms and anxiety, its clinical use has declined due to the availability of safer alternatives. Phenprobamate shares structural similarities with meprobamate, a well-known anxiolytic. While still studied for its pharmacological properties, its use is now limited due to safety concerns and potential dependence.

Reference

1: Demir B, Demir Y, Aksoy I, Kilic OH, Gucyetmez V, Savas HA. Phenprobamate dependence: a case report. Addict Behav. 2015 Jun;45:232-3. doi: 10.1016/j.addbeh.2015.01.037. Epub 2015 Feb 13. PMID: 25727392.
2: Duzenli T, Tanoglu A, Akyol T, Kara M, Yazgan Y. Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity. Euroasian J Hepatogastroenterol. 2019 Jan-Jun;9(1):49-51. doi: 10.5005/jp- journals-10018-1295. PMID: 31988867; PMCID: PMC6969320.
3: Sun JX, Embil K, Lee CS. Time-dependent absorption of phenprobamate following multiple dosing in rats. Pharm Res. 1988 Jun;5(6):387-90. doi: 10.1023/a:1015967829826. PMID: 3244651.
4: Emet M, Aslan S, Cakir ZG, Uyanik A, Uzkeser M, Hacimuftuoglu A, Emre H. Plasmapheresis is useful in phenprobamate overdose. Am J Emerg Med. 2009 Jun;27(5):626.e1-2. doi: 10.1016/j.ajem.2008.08.022. PMID: 19497474.
5: Tulunay FC, Onaran HO, Ergün H, Ucar A, Usanmaz S, Embil K, Tulunay M. Pharmacokinetics of phenprobamate after oral administration to healthy subjects. Arzneimittelforschung. 1998 Nov;48(11):1068-71. PMID: 9850426.
6: Sun JX, Embil K, Chow DS, Lee CC. High-performance liquid chromatographic analysis, plasma protein binding and red blood cell partitioning of phenprobamate. Biopharm Drug Dispos. 1987 Jul-Aug;8(4):341-51. doi: 10.1002/bdd.2510080405. PMID: 3620593.
7: Altun ML, Erk N. The rapid quantitative analysis of phenprobamate and acetaminophen by RP-LC and compensation technique. J Pharm Biomed Anal. 2001 Apr;25(1):85-92. doi: 10.1016/s0731-7085(00)00490-8. PMID: 11274861.
8: Farrier DS. The occurrence of 3-hydroxy-phenprobamate, a new metabolite of phenprobamate, in dogs and humans. Arzneimittelforschung. 1975 May;25(5):813-7. PMID: 1242331.
9: Tasdemir HA, Yildiran A, Islek I, Sancak R, Dilber C. Haemoperfusion may be useful in phenprobamate and polypharmacy intoxication of paediatric patients. Nephrol Dial Transplant. 2002 May;17(5):941. doi: 10.1093/ndt/17.5.941. PMID: 11981094.
10: Schatz F, Jahn U. Untersuchungen über Resorption und Metabolismus von gamma- Phenylpropylcarbamat (Phenprobamat) [Studies on the resorption and metabolism of gamma-phenylpropyl carbamate (Phenprobamate)]. Arzneimittelforschung. 1966 Jul;16(7):866-70. German. PMID: 6014716.